News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3126last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Benzinga Private Markets48d agoneutral
The $15.6B Smart Ring Bet: Oura Takes On Wall Street With IPOMotley Fool62d agoneutral
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?GuruFocus.com69d agobearish
Eli Lilly Stock Falls After Pharma Giant Unveils $2.9 Billion AcquisitionBarrons.com96d agoneutral
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are OpenInvestor's Business Daily97d agoneutral
Read Between These Lines As Eli Lilly, Hot IPO And More Face Key TestBarrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaGuruFocus.com111d agoneutral
Scribe Therapeutics Files $107.2 Million IPO as Sanofi Backs Share PurchaseInvestor's Business Daily114d agobullish
IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three MonthsInsider Monkey115d agobullish
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli LillyInvestor's Business Daily124d agoneutral
Eli Lilly's Market Cap Balloons Again On This IPO's SetbackInsider Monkey135d agoneutral
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 Agonists